We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Navient's (NAVI) Ratings Affirmed by Moody's, Outlook Stable
Read MoreHide Full Article
Navient Corporation’s (NAVI - Free Report) ratings have been affirmed by Moody's Investors Service. The Wilmington, DE-based lender’s senior unsecured debt rating has been reiterated as Ba3, senior unsecured debt shelf rating as (P)Ba3 and Corporate Family Rating as Ba3. Also, the outlook has remained stable.
Reasons Behind Unchanged Ratings
Moody’s stable ratings are reflective of Navient’s constant financial performance and good asset quality on the back of $105 billion student loan portfolio. Further, the rating agency is optimistic of Navient’s acquisition of Earnest, a financial technology company in November 2017. Per Moody’s, this acquisition might help Navient reduce the pace of declining net income if it focuses on development of new and existing businesses.
This acquisition is likely to boost Navient as it marks the company’s comeback in student loan origination market. After becoming one of the servicers to U.S. Department of Education under Direct Student Loan Program in 2010, the company stopped originating new FFELP loans. Earnest's student loan refinancing and personal loan offerings will support Navient’s declining loan portfolio, particularly private student loan portfolio.
Also, Moody’s was positive on Navient’s decision to suspend share buyback program in order to reduce leverage and focus on growing its private student lending portfolio. Also, it expects to resume buyback in the second half of 2018.
Moody's affirmed the outlook on expectations that Navient would continue to execute its origination strategy, maintain solid financial performance and current leverage levels along with conservatively managing its liquidity and funding requirements.
What Can Trigger Change in Moody’s Ratings
Rating for Navient can be upgraded in case Moody’s feels that the lender has successfully build its private loan originating business and reduced declining trend of its loan portfolio.
At the same time, ratings can go down if the financial performance of Navient deteriorates or the value of the investment portfolio declines.
The company’s shares have lost 9.8% in the past year against 2.8% growth of the industry.
Encore Capital Group (ECPG - Free Report) has witnessed an upward estimate revision of 10.4% in the last 60 days. Additionally, the stock has rallied more than 44% in the past year. It carries a Zacks Rank #2 (Buy).
Enova International (ENVA - Free Report) earnings estimates for the current year have been revised 5.2% upward over the last 60 days. Its shares have gained 55.9% in the past year. It carries a Zacks Rank of 2.
World Acceptance Corporation’s (WRLD - Free Report) earnings estimate have remained stable for the current year, over the last 30 days. The company’s shares have soared around 106.3% in a year’s time. It also carries a Zacks Rank of 2.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Navient's (NAVI) Ratings Affirmed by Moody's, Outlook Stable
Navient Corporation’s (NAVI - Free Report) ratings have been affirmed by Moody's Investors Service. The Wilmington, DE-based lender’s senior unsecured debt rating has been reiterated as Ba3, senior unsecured debt shelf rating as (P)Ba3 and Corporate Family Rating as Ba3. Also, the outlook has remained stable.
Reasons Behind Unchanged Ratings
Moody’s stable ratings are reflective of Navient’s constant financial performance and good asset quality on the back of $105 billion student loan portfolio. Further, the rating agency is optimistic of Navient’s acquisition of Earnest, a financial technology company in November 2017. Per Moody’s, this acquisition might help Navient reduce the pace of declining net income if it focuses on development of new and existing businesses.
This acquisition is likely to boost Navient as it marks the company’s comeback in student loan origination market. After becoming one of the servicers to U.S. Department of Education under Direct Student Loan Program in 2010, the company stopped originating new FFELP loans. Earnest's student loan refinancing and personal loan offerings will support Navient’s declining loan portfolio, particularly private student loan portfolio.
Also, Moody’s was positive on Navient’s decision to suspend share buyback program in order to reduce leverage and focus on growing its private student lending portfolio. Also, it expects to resume buyback in the second half of 2018.
Moody's affirmed the outlook on expectations that Navient would continue to execute its origination strategy, maintain solid financial performance and current leverage levels along with conservatively managing its liquidity and funding requirements.
What Can Trigger Change in Moody’s Ratings
Rating for Navient can be upgraded in case Moody’s feels that the lender has successfully build its private loan originating business and reduced declining trend of its loan portfolio.
At the same time, ratings can go down if the financial performance of Navient deteriorates or the value of the investment portfolio declines.
The company’s shares have lost 9.8% in the past year against 2.8% growth of the industry.
The stock carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Stocks to Consider
Encore Capital Group (ECPG - Free Report) has witnessed an upward estimate revision of 10.4% in the last 60 days. Additionally, the stock has rallied more than 44% in the past year. It carries a Zacks Rank #2 (Buy).
Enova International (ENVA - Free Report) earnings estimates for the current year have been revised 5.2% upward over the last 60 days. Its shares have gained 55.9% in the past year. It carries a Zacks Rank of 2.
World Acceptance Corporation’s (WRLD - Free Report) earnings estimate have remained stable for the current year, over the last 30 days. The company’s shares have soared around 106.3% in a year’s time. It also carries a Zacks Rank of 2.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>